传染科指南

订阅

MedSci主页 / 所有栏目 / 传染科指南

2021 ESCMID指南：多重耐药革兰氏阴性杆菌感染的治疗

2021-12-16 欧洲临床微生物与感染性疾病学会 Clin Microbiol Infect

细菌组多重耐药革兰氏阴性杆菌

2021年12月，欧洲临床微生物与感染性疾病学会(ESCMID)发布了多重耐药革兰氏阴性杆菌感染的治疗指南。

中文标题：

2021 ESCMID指南：多重耐药革兰氏阴性杆菌感染的治疗

英文标题：

European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM -European Society of intensive care Medicine)

发布机构：

欧洲临床微生物与感染性疾病学会

发布日期：

2021-12-16

简要介绍：

2021年12月，欧洲临床微生物与感染性疾病学会(ESCMID)发布了多重耐药革兰氏阴性杆菌感染的治疗指南。本文针对第三代头孢菌素耐药的肠杆菌和碳青霉烯类耐药的革兰氏阴性菌的靶向抗生素治疗，侧重个体抗生素的有效性以及联合治疗和单药治疗。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 ESCMID指南：多重耐药革兰氏阴性杆菌感染的治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=408551c00229e08d, title=2021 ESCMID指南：多重耐药革兰氏阴性杆菌感染的治疗, enTitle=European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM -European Society of intensive care Medicine), guiderFrom=Clin Microbiol Infect, authorId=0, author=, summary=2021年12月，欧洲临床微生物与感染性疾病学会(ESCMID)发布了多重耐药革兰氏阴性杆菌感染的治疗指南。, cover=https://img.medsci.cn/20211221/1640094110814_1608702.jpg, journalId=0, articlesId=null, associationId=166, associationName=欧洲临床微生物与感染性疾病学会, associationIntro=欧洲临床微生物与感染性疾病学会（ESCMID）成立于1983年，在德国注册。现在世界各地的正式会员有4100余人。它在微生物学和传染病学领域具有一定的影响力。, copyright=0, guiderPublishedTime=Thu Dec 16 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年12月，欧洲临床微生物与感染性疾病学会(ESCMID)发布了多重耐药革兰氏阴性杆菌感染的治疗指南。本文针对第三代头孢菌素耐药的肠杆菌和碳青霉烯类耐药的革兰氏阴性菌的靶向抗生素治疗，侧重个体抗生素的有效性以及联合治疗和单药治疗。</span></p>, tagList=[TagDto(tagId=26540, tagName=细菌组), TagDto(tagId=120206, tagName=多重耐药革兰氏阴性杆菌)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=5481, guiderKeyword=革兰氏阴性菌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3462, appHits=153, showAppHits=0, pcHits=1048, showPcHits=3307, likes=2, shares=20, comments=6, approvalStatus=1, publishedTime=Tue Dec 21 21:26:16 CST 2021, publishedTimeString=2021-12-16, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Tue Dec 21 21:32:06 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Fri Jan 05 02:36:58 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ESCMID指南：多重耐药革兰氏阴性杆菌感染的治疗.pdf)])
2021 ESCMID指南：多重耐药革兰氏阴性杆菌感染的治疗.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1242769, encodeId=3aef1242e6982, content=学习了。谢谢您的分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4381461333, createdName=lang2009.wo, createdTime=Fri Sep 02 11:21:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239707, encodeId=9df31239e0733, content=英文也看了材料也看了，非常不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:24:14 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239706, encodeId=44501239e06e3, content=十分感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:23:50 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203076, encodeId=fb2012030e6d7, content=十分受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Wed Mar 16 12:24:33 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203062, encodeId=379c120306219, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Wed Mar 16 11:49:17 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-09-02 lang2009.wo

    学习了。谢谢您的分享！

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1242769, encodeId=3aef1242e6982, content=学习了。谢谢您的分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4381461333, createdName=lang2009.wo, createdTime=Fri Sep 02 11:21:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239707, encodeId=9df31239e0733, content=英文也看了材料也看了，非常不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:24:14 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239706, encodeId=44501239e06e3, content=十分感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:23:50 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203076, encodeId=fb2012030e6d7, content=十分受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Wed Mar 16 12:24:33 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203062, encodeId=379c120306219, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Wed Mar 16 11:49:17 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-08-19 hai海

    英文也看了材料也看了，非常不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1242769, encodeId=3aef1242e6982, content=学习了。谢谢您的分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4381461333, createdName=lang2009.wo, createdTime=Fri Sep 02 11:21:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239707, encodeId=9df31239e0733, content=英文也看了材料也看了，非常不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:24:14 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239706, encodeId=44501239e06e3, content=十分感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:23:50 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203076, encodeId=fb2012030e6d7, content=十分受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Wed Mar 16 12:24:33 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203062, encodeId=379c120306219, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Wed Mar 16 11:49:17 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-08-19 hai海

    十分感谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1242769, encodeId=3aef1242e6982, content=学习了。谢谢您的分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4381461333, createdName=lang2009.wo, createdTime=Fri Sep 02 11:21:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239707, encodeId=9df31239e0733, content=英文也看了材料也看了，非常不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:24:14 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239706, encodeId=44501239e06e3, content=十分感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:23:50 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203076, encodeId=fb2012030e6d7, content=十分受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Wed Mar 16 12:24:33 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203062, encodeId=379c120306219, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Wed Mar 16 11:49:17 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-03-16 146e9e94m10(暂无昵称)

    十分受益

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1242769, encodeId=3aef1242e6982, content=学习了。谢谢您的分享！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a4381461333, createdName=lang2009.wo, createdTime=Fri Sep 02 11:21:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239707, encodeId=9df31239e0733, content=英文也看了材料也看了，非常不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:24:14 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239706, encodeId=44501239e06e3, content=十分感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24da5136519, createdName=hai海, createdTime=Fri Aug 19 11:23:50 CST 2022, time=2022-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203076, encodeId=fb2012030e6d7, content=十分受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Wed Mar 16 12:24:33 CST 2022, time=2022-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203062, encodeId=379c120306219, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJjdkFuFT9DxkzjiaO5tOZlWvxUdRETwQ5UJ0YfHLz4PJtLpWPTfJjwYBRzhz9OXLQAPH9LYibmER8A/132, createdBy=5d2a5176562, createdName=146e9e94m10(暂无昵称), createdTime=Wed Mar 16 11:49:17 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-03-16 146e9e94m10(暂无昵称)

    好

    0

相关指南

2021 HIS/IPS指南：医疗机构内耐甲氧西林金黄色葡萄球菌的预防和控制

医疗感染学会(HIS,Healthcare Infection Society) · 2021-10-16

拓展阅读

IDSA 抗微生物革兰氏阴性菌感染治疗指南：2.0 版

美国感染病学会(IDSA,Infectious Diseases Society of America) · 2021-11-22

2023 IDSA指南：抗菌药物耐药革兰氏阴性菌感染的治疗

美国感染病学会(IDSA,Infectious Diseases Society of America) · 2023-07-18